No Data
Analysts Offer Insights on Healthcare Companies: Madrigal Pharmaceuticals (MDGL), Travere Therapeutics (TVTX) and Regeneron (REGN)
Express News | Madrigal Pharmaceuticals Inc : B. Riley Raises Target Price to $236 From $194
Jefferies Maintains Madrigal Pharmaceuticals(MDGL.US) With Buy Rating, Maintains Target Price $400
Jefferies Keeps Their Buy Rating on Madrigal Pharmaceuticals (MDGL)
Echosens Führt Seine Liver Health Management (LHM)-Plattform Weltweit Ein Und Rationalisiert Die Leberversorgung
Apple Satellite Connectivity Provider Globalstar And Timberland Parent V.F Corp Are Among Top 7 Mid Cap Gainers Last Week (Oct 28-Nov 1): Are The Others In Your Portfolio?
No Data
No Data
